Business Context and Reporting Period
Company: E. I. du Pont de Nemours and Company (DuPont)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2008
Overview: DuPont is a global science and innovation leader operating in six reportable segments: Agriculture & Nutrition, Coatings & Color Technologies, Electronic & Communication Technologies, Performance Materials, Safety & Protection, and Pharmaceuticals. The company employs approximately 60,000 people across 90 countries, with 64% of net sales generated outside the U.S.
Key Financial Metrics (2008)
| Metric | 2008 Value | 2007 Value |
|---|---|---|
| Net Sales | $30,529 million | $29,378 million |
| Net Income | $2,007 million | $2,988 million |
| Diluted EPS | $2.20 | $3.22 |
| Operating Cash Flow | $3,129 million | $4,290 million |
| Total Assets | $36,209 million | $34,131 million |
| Total Debt | $9,650 million | $7,325 million |
| Working Capital | $5,601 million | $4,619 million |
| Stockholders' Equity | $7,125 million | $11,136 million |
Note: Total Debt includes short-term borrowings ($2,012 million) and long-term borrowings ($7,638 million). Stockholders' equity decreased significantly due to a $4.7 billion other comprehensive loss driven by pension plan actuarial losses.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 4% to $30.5 billion, driven by a 7% increase in local selling prices and a 3% favorable currency effect. This growth was offset by a 5% decline in sales volume, which accelerated in the fourth quarter due to the global recession.
- Profitability Decline: Net income fell 33% to $2.0 billion. The decline was primarily caused by lower sales volumes, higher raw material and energy costs, and significant one-time charges.
- Restructuring Charges: The company recorded a $535 million pre-tax restructuring charge in the fourth quarter to align costs with lower demand. This included $287 million for employee severance and $248 million for asset-related charges.
- Hurricane Impact: A $227 million charge was recorded for hurricane-related cleanup, repair, and inventory write-offs, primarily affecting the Performance Materials segment.
- Debt Increase: Total debt increased by $2.4 billion to $9.7 billion as the company increased borrowings to maintain liquidity and fund general corporate purposes amidst tightening credit markets.
Guidance, Outlook, and Risks
2009 Outlook:
- Earnings Guidance: DuPont anticipates earnings in the range of $2.00 to $2.50 per share for 2009, reflecting the adverse impact of the global economic recession.
- Cost Reduction: The company plans to achieve $730 million in fixed cost reductions and a $1 billion reduction in net working capital in 2009.
- Capital Spending: Capital expenditures are targeted at approximately $1.6 billion for 2009, representing a 10-20% reduction from 2008 levels.
Key Risks and Contingencies:
- Global Recession: Continued weakness in motor vehicle and construction markets, particularly in North America and Western Europe, poses a significant risk to demand.
- PFOA Litigation: Ongoing environmental and litigation matters related to perfluorooctanoic acid (PFOA) at the Washington Works site. While the company has established reserves, potential liabilities could exceed accrued amounts if scientific panels find links to disease.
- Environmental Liabilities: Accrued environmental remediation liabilities totaled $379 million. Under adverse circumstances, potential liability could range up to two to three times this amount.
- Pharmaceuticals: Income from Cozaar/Hyzaar is expected to step down significantly starting in 2010 as U.S. patents expire.
Investor Verification Checklist
- Restructuring Execution: Verify the timeline and cash outflow for the $535 million restructuring program, specifically the 2,500 job cuts and site closures planned for 2009-2010.
- Pension Funding: Review the funded status of pension plans, which showed a significant underfunding gap ($5.3 billion) due to market losses and actuarial adjustments.
- Volume Trends: Monitor fourth-quarter sales volume trends to assess the severity of demand destruction in automotive and construction sectors.
- PFOA Developments: Track the progress of the independent science panel studying PFOA health effects, as a finding of a "probable link" could trigger up to $235 million in medical monitoring costs.
- Liquidity Position: Confirm the utilization of the $2.7 billion in available credit lines and the company's ability to service increased debt levels in a volatile credit market.